OR WAIT null SECS
October 28, 2024
With the design of the new 360,000 square-foot building, the CDMO’s goal is to continue to modernize its Laupheim site.
October 08, 2024
With the implementation of unit-level traceability, the collaboration is expected to provide additional visibility not only within the aseptic manufacturing process, but the entire supply chain overall.
October 04, 2024
The goal is to provide greater access to HIV prevention drugs in low-income countries.
October 03, 2024
Why it's critical for companies to set long-term, strategic goals in their journeys toward decarbonization.
October 02, 2024
New facilities are expected to focus on manufacturing next-generation medicines and biologic medicines.
September 16, 2024
It’s essential for commercial success, but presents its share of obstacles.
September 09, 2024
The project is funded by Scottish Enterprise, and aims to boost commercial manufacturing of injectable drug product.
September 06, 2024
The enhancement—which complements the CDMO’s adeno-associated viral vector services—will be utilized at the company’s advanced therapies site in Stevenage, UK.
September 04, 2024
The project features several enhancements, including a new 67,000 square-foot warehouse at its HQ.
August 30, 2024
The company also participated in the coalition’s pilot inspection program, making it the first CDMO to do so.